David L. Lucchino - Feb 17, 2022 Form 4 Insider Report for Frequency Therapeutics, Inc. (FREQ)

Role
President and CEO, Director
Signature
/s/ James P. Abely, Attorney-in-Fact for David L. Lucchino
Stock symbol
FREQ
Transactions as of
Feb 17, 2022
Transactions value $
$0
Form type
4
Date filed
2/18/2022, 03:18 PM
Previous filing
Jan 20, 2022
Next filing
Aug 19, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FREQ Restricted Stock Unit Award $0 +300K $0.00 300K Feb 17, 2022 Common Stock 300K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive on share of Issuer common stock.
F2 The restricted stock units will fully vest on July 4, 2023.